HOME >> BIOLOGY >> NEWS
Technological advances making life easier for people with physical and mental challenges

DENVER, CO - Screen displays that deliver the written word to people who are sight-impaired, the latest ear implants for those who are deaf, and tools for individuals with mental challenges are on the cusp of a major technological revolution, paralleled by a growing aging population.

Developing and testing new devices for people with disabilities in real-world environments should enhance lab research, but sense-heightening technologies cannot replace the development of reading and writing skills, which are essential for understanding language and math, according to scientists at the 2003 American Association for the Advancement of Science (AAAS) Annual Meeting.

Missing the ability to see does not have to preclude a person from pursuing a career of one's choice, however, if new technology heedlessly tips people who are blind away from studying Braille reading, it can do more harm than good, said Kent Cullers, the inspiration and real-life man behind the blind physicist character in the 1997 movie, Contact.

"A whole generation of blind people is being imperiled by the use of cheap speech 'displays' in preference to more expensive Braille," said Cullers, who is Director of SETI (Search for Extra Terrestrial Intelligence) Research and Development in Mountain View, California.

Although the evolution of computers and other technological devices helps power the "extension of the senses," Braille is still needed in order to understand language and math, explained Cullers, who has been blind since birth. "Like everyone who produces careful work, blind people must read and write!"

Among the totally blind, about 75 percent are unemployed. However, almost 9 out of 10 of the totally blind who are employed read Braille. Therefore, Cullens said, it is plausible that Braille reading, as with reading in general, imbues workers with the skills needed for competent performance.

Still, much professional material is not easily availa
'"/>


16-Feb-2003


Page: 1 2 3

Related biology news :

1. Grant advances biochemical engineering laboratory
2. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
3. Undergraduate research experience advances education
4. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders
5. UCSF finding advances insight into adult stem cells in human brain
6. Federal grant supports advances in infant heart disease at Childrens Hospital of Philadelphia
7. Human embryonic stem cells may promise medical advances
8. Scientists making advances in cancer prevention, detection and treatment to receive awards
9. New advances in thrombosis help further understanding of disease prevention
10. Conference to highlight medical advances resulting from 50 years of DNA knowledge
11. Annual bibliography of significant advances in dietary supplement research 2002

Post Your Comments:
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: